Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

7.18
+0.05000.70%
Volume:63.38K
Turnover:451.66K
Market Cap:580.87M
PE:-5.67
High:7.21
Open:7.13
Low:7.02
Close:7.13
52wk High:18.31
52wk Low:6.52
Shares:80.90M
Float Shares:63.93M
Volume Ratio:0.33
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2659
EPS(LYR):-3.0342
ROE:-3489.00%
ROA:-8.80%
PB:-1.69
PE(LYR):-2.37

Loading ...

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

GlobeNewswire
·
May 20

Phathom (PHAT) Is Up 9.4% After Reaffirming 2026 Profitability Timeline And Narrowing Q1 Loss

Simply Wall St.
·
May 09

Phathom to highlight VOQUEZNA at DDW annual meeting

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Phathom Pharmaceuticals (PHAT) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
May 01

Phathom Pharmaceuticals Signals Strong Growth on Earnings Call

TIPRANKS
·
May 01

Phathom Pharmaceuticals Q1 Adj. EPS $(0.18) Beats $(0.32) Estimate, Sales $58.301M Beat $57.028M Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -30.369 Million

Reuters
·
Apr 30

Phathom Pharmaceuticals Q1 Adjusted EPS USD -0.18 VS. Ibes Estimate USD -0.32

THOMSON REUTERS
·
Apr 30

Phathom Pharmaceuticals Inc - Maintains FY2026 Guidance; Expects Operating Profitability Beginning Q3 2026

THOMSON REUTERS
·
Apr 30

Phathom Pharmaceuticals Q1 Revenue USD 58.301 Million VS. Ibes Estimate USD 57 Million

THOMSON REUTERS
·
Apr 30

Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Apr 30

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health (GH)

TIPRANKS
·
Apr 28

Phathom Pharmaceuticals to report first-quarter results, host webcast and conference call

Reuters
·
Apr 20

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

GlobeNewswire
·
Apr 20

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Recent Stock Momentum Shift

Simply Wall St.
·
Apr 15